RNA antagonist compounds for the inhibition of Apo-B100 expression

Details for Australian Patent Application No. 2008228243 (hide)

Owner Santaris Pharma A/S

Inventors Hansen, Henrik Frydenlund; Rosenbohm, Christoph; Straarup, Ellen Marie; Hansen, Bo

Agent FB Rice

Pub. Number AU-A-2008228243

PCT Pub. Number WO2008/113830

Priority 60/896,419 22.03.07 US; 60/977,409 04.10.07 US

Filing date 19 March 2008

Wipo publication date 25 September 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/113830 Priority application(s): WO2008/113830

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008228246-Novel human anti-R7V antibodies and uses thereof

2008228229-Glove